14th Jun 2006 07:01
AGI Therapeutics plc14 June 2006 AGI Therapeutics plc ("AGI" or the "Company") Director's Dealing The Company was informed on 13 June 2006 that on that day Ronan Lambe, nonexecutive chairman of AGI, acquired 250,000 ordinary shares of €0.01 each ("Ordinary Shares") in the share capital of the Company at €1.35 per OrdinaryShare. At the date of this announcement, Ronan Lambe has an interest in 646,825Ordinary Shares representing approximately 1% of the Company's issued sharecapital. Contact Information: David G. Kelly, Chief Financial Officer Tel: +353 1 449 3254 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Potentially Ai